Scientists have begun testing a vaccine for patients with an aggressive form of breast cancer.

The vaccine targets women previously treated for the highly-recurring triple negative breast cancer.

Scientists said they are hoping the vaccine can prevent the cancer from coming back by killing cancer cells after chemotherapy. Triple negative breast cancer accounts for 15 to 20 percent of all breast cancers.

Join our Newsletter for the latest news right to your inbox